Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Siyi Intelligence is a China-based healthcare technology and medical device company focused on rehabilitation robotics for hospitals, community settings, and home use. The company develops and commercializes robotic rehabilitation systems including soft robotic hand rehabilitation gloves, lower-limb exoskeleton devices, upper-limb rehabilitation robots, EEG-based assistive brain-computer interface systems, and related electrostimulation products. Its products are marketed under brands including SYREBO and Yisheng and have received multiple regulatory certifications, including China NMPA registrations as well as references to FDA and CE certifications on company materials. Siyi positions itself as a provider of integrated neurorehabilitation solutions and a digital rehabilitation service platform, with products deployed internationally across dozens of countries and thousands of medical institutions. Overall, it is best characterized as a commercial-stage rehabilitation robotics and medtech company rather than a therapeutics-focused biotech or pharma developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Siyi Intelligence.